Abstract:The ongoing debate regarding pathway selective hepatic insulin resistance (IR) focuses on potential insulin signaling branchpoints beyond which regulation of glucose metabolism is attenuated and regulation of de novo lipogenesis (DNL) remains intact. These models suggest that impaired insulin receptor kinase activity, proximal to any potential branchpoint, only plays a minor role in clinical hepatic IR. We compared insulin signaling in liver biopsies from human subjects with nonalcoholic fatty liver disease (NAFLD) and hepatic IR vs. weight matched controls, using glucose ingestion to drive insulin secretion and fructose ingestion as a low insulin comparator. Insulin signaling through phosphorylation of insulin receptor β, Akt, and GSK3β was suppressed in NAFLD (all P < 0.05). Insulin regulation of mTORC1 via PRAS40 phosphorylation was absent in NAFLD subjects; no differences were seen between controls and NAFLD subjects in AMPK dependent RAPTOR phosphorylation. Pathway selective IR implies SREBP1c is primarily responsible for DNL in the insulin resistant liver; we probed the transcriptional regulation of DNL by assessing the in vivo occupancy of lipogenic target gene promoters by SREBP1c and ChREBP using ChIP experiments in mice with diet-induced IR. Fasted-refed mice were refed with high fat diet (HFD) and 1% dextrose drinking water. Mice with hepatic IR (9 day HFD fed) or hepatic and peripheral IR (4 week HFD fed) were compared with more insulin sensitive 2 day HFD fed mice. SREBP1c was not bound to the Fasn promoter in insulin resistant livers, while ChREBP was bound to the Fasn promoter equally in all three groups of mice. Conclusions: There is a proximal block in insulin signaling in humans with hepatic IR and NAFLD, dissociating previously measured changes in DNL rates from insulin signaling. SREBP does not mediate DNL in insulin resistant mice while ChREBP action can explain the maintenance of the transcriptional program of lipogenesis. Disclosure D.F. Vatner: None. K.W. ter Horst: None. L. Goedeke: None. D. Zhang: None. V. Samuel: None. M.J. Serlie: Advisory Panel; Self; Fresenius Medical Care. G.I. Shulman: Advisory Panel; Self; AstraZeneca, Janssen Research & Development, Merck & Co., Inc. Advisory Panel; Spouse/Partner; Merck & Co., Inc. Board Member; Self; Novo Nordisk A/S. Consultant; Self; Aegerion Pharmaceuticals, IMetabolic BioPharma Corporation, Longitude Capital, Nimbus Discovery, Inc., Staten Biotechnology B.V. Funding National Institutes of Health

Insulin-Regulated Srebp-1c And Pck1 Mrna Expression In Primary Hepatocytes From Zucker Fatty But Not Lean Rats Is Affected By Feeding Conditions

Zucker Lean and Fatty Rat Hepatocytes Respond Differently to Insulin and Retinoids in the Expression of Glucose and Lipid Metabolic Genes

Effects of Long-Term High-Fat/High-Energy and High-Protein Diets on Insulin and Ghrelin Expression in Developing Rats

Hepatic CREBZF Couples Insulin to Lipogenesis by Inhibiting Insig activity and Contributes to Hepatic Steatosis in Diet-Induced Insulin-Resistant Mice.

Vitamin A And Feeding Statuses Modulate The Insulin-Regulated Gene Expression In Zucker Lean And Fatty Primary Rat Hepatocytes

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

The Hepatic Raldh1 Expression is Elevated in Zucker Fatty Rats and Its Over-Expression Introduced the Retinal-Induced Srebp-1c Expression in INS-1 Cells.

The regulation of gene expression by insulin is differentially impaired in the liver of the genetically obese-hyperglycemic Wistar fatty rat

Berberine Regulated Gck, G6pc, Pck1 And Srebp-1c Expression And Activated Amp-Activated Protein Kinase In Primary Rat Hepatocytes

Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPAR-α and insulin-dependent signalling in hepatocytes

Retinoids Induced Pck1 Expression and Attenuated Insulin-Mediated Suppression of Its Expression Via Activation of Retinoic Acid Receptor in Primary Rat Hepatocytes

283-LB: Dissociating Insulin Signaling and SREBP1c Action from the Lipogenic Drive Seen in Human and Murine Hepatic Insulin Resistance

Down-regulation of Hepatic HNF4alpha Gene Expression During Hyperinsulinemia Via SREBPs.

Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity.

Increased Carnitine Palmitoyl Transferase 1 Expression and Decreased Sterol Regulatory Element–binding Protein 1c Expression Are Associated with Reduced Intramuscular Triglyceride Accumulation after Insulin Therapy in High-Fat–diet and Streptozotocin-Induced Diabetic Rats

Activation of the canonical ER stress IRE1-XBP1 pathway by insulin regulates glucose and lipid metabolism

High Insulin Concentrations Repress Insulin Receptor Gene Expression in Calf Hepatocytes Cultured in Vitro.

The Role of Acyl-CoA Synthetase 1 in Bioactive Lipid Accumulation and the Development of Hepatic Insulin Resistance

Inhibition of Hepatocyte Nuclear Factor 1b Induces Hepatic Steatosis Through DPP4/NOX1-mediated Regulation of Superoxide.

Insulin Treatment Can Improve Hepatic Lipid Accumulation in Rats with Type 2 Diabetes Through Adiponectin Receptor 2/peroxisome Proliferator-Activated Receptor-Α Signaling Pathway

Expression of LXR in rats with obesity or hyperglycemia and its impact on PEPCK expression in liver